sec filing
NV
NASDAQ · NVCT
Nuvectis Pharma, Inc.
Healthcare · Biotechnology
$23.99
Down-$0.49 (-2.04%)
Updated Sep 14, 2026, 4:04 PM
SID Score
5.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 192.83M
- P/E ratio
- -7.29
- Dividend yield
- 0.00%
- 52-week range
- $7.17 – $29.28
- Volume
- 221.08K
- Avg. volume
- 105.27K
Price performance
NVCT price history
1M range · 19 trading sessions · Daily adjusted prices
NVCT closed at $23.99 after 19 trading sessions, up 25.73% for the selected period.
- Last close
- $23.99
- Period change
- +25.73%
- Period low
- $19.08
- Period high
- $25.89
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | $22.96 | $24.24 | $22.28 | $23.99 | 221.08K |
| Sep 10, 2026 | $22.09 | $23.02 | $22.01 | $22.49 | 107.05K |
| Sep 9, 2026 | $23.89 | $24.5399 | $22.67 | $22.78 | 165.63K |
| Sep 8, 2026 | $24.00 | $24.6897 | $22.73 | $23.99 | 136.31K |
| Sep 4, 2026 | $24.00 | $25.19 | $23.96 | $24.49 | 117.17K |
| Sep 3, 2026 | $24.00 | $24.62 | $22.82 | $24.37 | 135.97K |
| Sep 2, 2026 | $23.06 | $24.01 | $23.06 | $23.92 | 188.61K |
| Sep 1, 2026 | $22.80 | $23.81 | $22.77 | $23.06 | 176.93K |
| Aug 31, 2026 | $23.52 | $24.35 | $22.57 | $22.73 | 192.57K |
| Aug 28, 2026 | $24.93 | $25.65 | $23.29 | $23.73 | 137.2K |
| Aug 27, 2026 | $25.03 | $25.84 | $24.35 | $25.19 | 319.9K |
| Aug 26, 2026 | $25.80 | $25.80 | $23.84 | $25.00 | 362.89K |
| Aug 25, 2026 | $23.90 | $25.9399 | $23.85 | $25.89 | 276.63K |
| Aug 24, 2026 | $23.56 | $24.55 | $23.335 | $23.87 | 231.13K |
| Aug 21, 2026 | $23.59 | $23.9299 | $22.83 | $23.56 | 196.98K |
| Aug 20, 2026 | $22.98 | $23.99 | $22.36 | $23.35 | 230.01K |
| Aug 19, 2026 | $21.44 | $23.74 | $21.00 | $23.33 | 362.93K |
| Aug 18, 2026 | $19.13 | $20.91 | $19.06 | $20.91 | 217.87K |
| Aug 17, 2026 | $18.85 | $19.32 | $18.51 | $19.08 | 102.6K |
Latest NVCT news
The latest Smart Investors Daily articles mentioning NVCT.
Stock researchCompany · Forecast
Loading stock research…